The cell line development market size is expected to experience a 10.3% CAGR from 2024 to 2032, driven by an increase in ...

XiltriX North America is the only real-time environmental monitoring provider in the life science industry that holds ISO ...

MONTVILLE, NJ / ACCESSWIRE / September 17, 2024 / The World Tumor Registry ("WTR"), a comprehensive, searchable, open-access ...

HOUSTON, TX / ACCESSWIRE / September 17, 2024 / Modern Foot & Ankle is pleased to welcome Dr. Phi Huynh, DPM, to its growing ...

SEATTLE, WA / ACCESSWIRE / September 17, 2024 / MD Clarity, a leading provider of revenue optimization software, today announced the launch of a major expansion of its contract modeling module. This ...

CHICAGO, IL / ACCESSWIRE / September 17, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative ...

Scientists are developing breast cancer risk tools that will help to identify women at high risk, even if they do not have a family history of the disease, thanks to one of the world’s largest and ...

OrganaBio is responding to sharply rising demand from pharmaceutical companies for donor material from patients with chronic diseases like lupus and psoriatic arthritis, to enable advanced therapies ...

Arca BioLogistics has joined forces with Cen Global, one of the UK’s leading providers of transport and logistics systems, to transform the delivery of life science and healthcare products across the ...

A Knowledge Transfer Partnership with Alpharmaxim has developed the world’s first evidence-based behaviour change tool to support the adoption of new drugs for rare and complex diseases.The approach ...

Corp. (OTC PINK:CBDW) (the "Company" or "1606") is pleased to announce it has signed a Letter of Intent to acquire a strategic stake in Adnexus Biotechnologies Inc., a pioneering company in Artificial ...

MinervaX scaling up supply of novel GBS vaccine, ahead of phase III studies ·         Wacker Biotech to manufacture active vaccine protein ingredients and prepare for commercial supply after ...